Margetuximab Medication Information

Discover comprehensive details about Margetuximab, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it.

The updated prescription information covers potential side effects, precautions, warnings, and storage recommendations.

Additionally, explore the Margetuximab brands available in India and internationally, along with pricing information. For personalized advice, consult your healthcare provider.

Generic Name : Margetuximab

Pronunciation : MAR-jeh-TUK-sih-mab

Brand Names or Trade Names of Margetuximab

India :

Margenza

Overview of Margetuximab

Margetuximab is an anticancer agent indicated for the treatment of breast cancer. It should be used along with chemotherapy for treating adults with HER (human epidermal growth factor receptor)-2 positive breast cancer that has spread to other places, who have received two or more prior regimens. HER2-positive breast cancer is cancer that tests positive for a protein named human epidermal growth factor receptor 2.

Why is Margetuximab Prescribed? (Indications)

Margetuximab is an anticancer agent indicated for the treatment of breast cancer.

When should Margetuximab not be taken? (Contraindications)

Patients allergic to Margetuximab

What is the dosage of Margetuximab?

Margetuximab is available as an injection

How should Margetuximab be taken?

The recommended dosage is 15 mg/kg body weight, given as an intravenous infusion over 2 hours for the initial dose, then over a minimum of 30 minutes every 3 weeks for all subsequent doses.
It should be given immediately after giving chemotherapy

Missed a Dose?

If a planned dose of Margetuximab is missed, administer the dose as soon as possible and adjust the treatment schedule accordingly, maintaining the treatment interval.

What are the warnings and precautions for Margetuximab?

• Pregnant and lactating women should avoid using this drug

• Monitor women who received the drug during pregnancy or within 4 months prior to conception for oligohydramnios- a low amount of amniotic fluid in the womb.

• Safety of usage was not known yet in children

What are the side effects of Margetuximab?

•General: Infusion-related reactions, tiredness, fever
•Digestive: Nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite
•Respiratory: Cough, dyspnea
•Joints: Muscle pain, joint pain
•Others: Hair fall, neuropathy

What are the other precautions for Margetuximab?

•Infusion-related reactions can occur. If a reaction occurs, the infusion must be discontinued.
•Females of reproductive potential to use effective contraception during treatment and for 4 months following the last dose of Margetuximab.
•The drug may cause a decrease in heart-pumping ability. Evaluate cardiac function prior to administering the drug and during treatment.